Review On Suspension & Nanosuspension
الموضوعات :Chetan Borase 1 , Amol Jagdale 2 , Monika Sonawane 3 , Akshay Katkale 4 , ROSHAN LANDGE 5 , Shubham kothawade 6
1 - MVP college of Pharmacy nashik
2 - NDMVP SAMAJ COLLEGE OF PHARMACY NASHIK
3 - NDMVP COLLEGE OF PHARMACY
4 - NDMVP SAMAJ COLLEGE OF PHARMACY NASHIK
5 - NDMVP COLLEGE OF PHARMACYNASHIK
6 - NDMVP SAMAJ COLLEGE OF PHARMACY ,NASHIK
الکلمات المفتاحية: Suspensions, Suspending agents, Stability, Dissolution, Nanosuspension,
ملخص المقالة :
Pharmaceutical Suspension is a coarse dispersion of insoluble solid particles in a liquid medium. The particle diameter of the suspension is usually greater than 0.5 μm. However, establishing sharp boundaries between suspensions and dispersions with finer particles is difficult and impractical. Suspensions are an important class of pharmaceutical dosage forms. Advantages of suspension formulations include effective administration of hydrophobic drugs; refusal to use co-solvents; It masks the unpleasant taste of some ingredients. ensuring resistance to degradation of drugs due to hydrolysis, oxidation or microbial activity; It can be easily swallowed by young and elderly patients. Effective intramuscular depot therapy. In addition, relatively higher drug concentrations may be included in suspension products compared to solution formulations. This review provides an overview of various aspects of suspensions, such as classification of suspensions, suspension theory, various suspending agents, aspects of suspension formulations, packaging of suspensions, evaluation of suspensions, stability of suspensions, and recent research in progress. pendant. Solubility is a decisive factor in the effectiveness of a drug regardless of the route of administration. Most of the recently discovered drugs are insoluble in water and have low bioavailability, so development has failed. These so-called "Brickellia" candidates can now be formulated and delivered as nanosuspensions. Nanosuspension technology solves the problem of drugs that are poorly soluble in water and have low bioavailability. Nanosuspension technology can be used to improve drug stability and bioavailability. The preparation of nanosuspension is simple and applicable to all water-insoluble drugs. Nanosuspensions are prepared using wet mills, high pressure homogenizers, emulsion and solvent evaporation, melt emulsification, and supercritical fluid methods. Nanosuspensions can be prepared using stabilizers, organic solvents and other additives such as buffers, salts, polyols, osmagents and cryoprotectants
1. Martins I, Esteves J, Silva FP da, Tomé A. Automobile Suspensions Using Electromagnetic Linear Actuators. IFAC Proceedings Volumes [Internet]. 2000 Sep;33(26):203–8.
2. Bello MM, Akramin Shafie A, Khan R. Active Vehicle Suspension Control Using Full State-Feedback Controller. Advanced Materials Research. 2015 Jul;1115(17327):440–5.
3. Gao L, Zhang D, Chen M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. Journal of Nanoparticle Research. 2008 Mar 22;10(5):845–62.
4. Mathew M, Krishnakumar K, Dineshkumar B, Nair SK. ANTIBIOTICS NANOSUSPENSION: A REVIEW. Journal of Drug Delivery and Therapeutics. 2017 Mar 15;7(2).
5. Patel M, Shah T, Amin A. Therapeutic Opportunities in Colon-Specific Drug-Delivery Systems. Critical Reviews in Therapeutic Drug Carrier Systems. 2007;24(2):147–202.
6. Shah DP, Patel B, Shah C. NANOSUSPENSION TECHNOLOGY: A INNOVATIVE SLANT FOR DRUG DELIVERY SYSTEM AND PERMEABILITY ENHANCER FOR POORLY WATER SOLUBLE DRUGS. Journal of Drug Delivery and Therapeutics. 2015 Jan 15;5(1).
7. L N. Nanotechnology in development of drug delivery system. Open Access Journal of Pharmaceutical Research. 2017;1(5).
8. BP, P. A Review On Techniques Which Are Useful For Solubility Enhancement Of Poorly Water Soluble Drugs,. International Journal For Research In Management And Pharmacy, 1, 2012, 56-70. 2012;56–70.
9. Ismail S, El-Mahdy M, Al-Kubati S. ENHANCEMENT OF SOLUBILITY AND DISSOLUTION OF NIMESULIDE USING SOLUBILIZATION, SOLID DISPERSION AND COMPLEXATION TECHNIQUES. Bulletin of Pharmaceutical Sciences Assiut. 2009 Dec 31;32(2):321–38.
10. Chaudhary A, Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: A recent review, Journal of Advanced Pharmacy Education & Research, 2 (1), 2012, 32- 67.
11. Kapadiya N, Hydrotropy: A Promising Tool for Solubility Enhancement: A Review. International Journal of Drug Development & Research, 3, 2011, 26-33.
12. Thorat YS, Solubility Enhancement Techniques: A Review On Conventional And Novel Approaches, IJPSR, 2(10), 2011, 2501-2513.
13. Sharma D, Solubility Enhancement – Eminent Role in Poorly Soluble Drugs, “Research J. Pharm. and Tech”, 2(2), 2009, 220-224.
14. Jain S, Solubility Enhancement By Solvent Deposition Technique: An Overview, Asian Journal Of Pharmaceutical And Clinical Research, 5(4), 2012, 15-19.
15. N.A.M.Deecaraman, C.Rani, Mohanraj KP, Kumar KV, preparation and solid state characterization of atorvastatin nanosuspensions for enhanced solubility and dissolution, International Journal of PharmTech Research, 1, 2009,.
16. Patel DJ, Patelj K, Pandya VM, 3rishad R. Jivani RR, Patel RD, Optimization of Formulation Parameters On Famotidine Nanosuspension Using Factorial Design And The Desirability Function, International Journal of PharmTech Research, 2, 2010, 155-161.
17. Patil MS, Preparation And Optimization of Simvastatin Nanoparticle For Solubility Enhancement And In- Vivo Study, International Journal of Pharma Research and Development – Online, 2, 2011, 219-226.
18. Wei Li, Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension, International Journal of Pharmaceutics, 408, 2011, 157-162.
19. Jorvekar.P, Pathak AA, Chaudhari PD, Formulation Development of Aceclofenac Loaded Nanosuspension by Three Square (32) Factorial Design, International Journal Of Pharmaceutical Sciences and Nanotechnology, 4, 2012, 1575-1582.
20. Banavath H. Sivarama RK, Tahir A, Sajid A, Pattnaik G, Nanosuspension: an attempt to enhance bioavailability of poorly soluble drugs, International Journal of Pharmaceutical Science and Research, 1(9), 2010, 1-11.
21. Shegokar R, Müller RH, Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives, International Journal of Pharmaceutics, 399, 2010, 129–139.
22. Chingunpituk J, Nanosuspension Technology for Drug Delivery, Walailak J Sci & Tech, 4(2), 2007, 139-153.
23. ]. Patravale B, Abhijit AD, Kulkarni RM, Nanosuspensions: a promising drug delivery strategy, Journal of Pharmacy and Pharmacoloy, 56, 2004, 827–840.
24. Prasanna L, Nanosuspension Technology: A Review, International Journal of Pharmacy and Pharmaceutical Sciences, 2( 4), 2010, 35-40.
25. Xiaohui P, Jin S, Mo L, Zhonggui H, Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs, Current Nanoscience, 5, 2009, 417- 427.
26. Mohanty S, Role of Nanoparticles in Drug Delivery System, International Journal of Research in Pharmaceutical and Biomedical Sciences, 1 (2), 2010, 41-66.
27. Ch.P, A Review On Nanosuspensions In Drug Delivery, International Journal Of Pharma and Bio Sciences, 2, 2011, 549-558.
28. Nagare SK, A review on Nanosuspension: An innovative acceptable approach in novel delivery system, Universal Journal of Pharmacy, 1(1), 2012, 19-31.
29. Debjit B, Nanosuspension -A Novel Approaches In Drug Delivery System, The Pharma Innovation – Journal, 1(12), 2012, 50-63.
30. Kamble VA, Nanosuspension A Novel Drug Delivery System, International Journal of Pharma And Bio Sciences, 1, 2010, 352-360.
31. Soni S, Nanosuspension: An Approach to Enhance Solubility of Drugs, IJPI’s Journal of Pharmaceutics and Cosmetology, 2(9), 2012, 50-63.
32. Soni S, Nanosuspension: An Approach to Enhance Solubility of Drugs, IJPI’s Journal of Pharmaceutics and Cosmetology, 2(9), 2012, 50-63.
33. Patel M, Nanosuspension: A Novel Approch For Drug Delivery System, JPSBR, 1, 2011, 1-10.
34. Shelke PV, A Review On Formulation And Evaluation of Nanosuspension, International Journal of Universal Pharmacy And Life Sciences, 2(3), 2012, 516-524.
35. Venkatesh T, Nanosuspensions: Ideal Approach for the Drug Delivery of Poorly Water Soluble Drugs, Der Pharmacia Lettre, 3(2), 2011, 203-213.
36. Yadav GV, Nanosuspension: A Promising Drug Delivery System, Pharmacophore, 3(5), 2012, 217-243.
37.Pandey S, Nanosuspension: Formulation, Charcterization and Evaluation, International Journal of Pharma and Bio Sciences, 1(2), 2010, 1-10.
38. Toshi C, A Review on Nanosuspensions promising Drug Delivery Strategy, Current Pharma Research, 3(1), 2012, 764-776.
39. Ezeddin K, Nanodispersions Platform for Solubility Improvement, International Journal of Research in Pharmaceutical and Biomedical Sciences, 4 (2), 2013, 636- 643.
40. Kumar GP, Nanosuspensions: The Solution to Deliver Hydrophobic Drugs, International Journal of Drug Delivery, 3, 2011, 546-557.
41. ] Venkatesh T, Nanosuspensions: Ideal Approach for the Drug Delivery of Poorly Water Soluble Drugs, Der Pharmacia Lettre, 3(2), 2011, 203-213.
42. Paun JS, Nanosuspension: An Emerging Trend for Bioavailability Enhancement of Poorly Soluble Drugs, Asian J. Pharm. Tech, 2(4), 2012, 157-168.
43. Vaghela A, Nanosuspension Technology, International Journal of Universal Pharmacy and Life Sciences, 2(2), 2012, 306-317.
44. Vaghela A, Nanosuspension Technology, International Journal of Universal Pharmacy and Life Sciences, 2(2), 2012, 306-317.
45. Bhargavi A, Technical Review of Nanosuspensions, International Journal of Pharmacy & Technology, 3(3), 2011, 1503-1511.
46. Verma KAK, Nanosuspensions: Advantages and Disadvantages, Indian Journal of Novel Drug Delivery, 4(3), 2012, 179-188.
47. Vaghela A, Nanosuspension Technology, International Journal of Universal Pharmacy and Life Sciences, 2(2), 2012, 306-317.
48. Srinivasa RK, an Overview of Statins as Hypolipidemic Drugs, International Journal of Pharmaceutical Sciences and Drug Research, 3(3), 2011, 178-183.
49. Nagaraju P, Nanosuspension: A Promising Drug Delivery System, International Journal of Pharmaceutical Sciences and Nanotechnology, 2(4), 2010, 679-684.
50. Koteshwara KB, Nanosuspension: A Novel Drug Delivery Approach, IJRAP, 2(1), 2011, 162-165.
51. ] Mudgil M, Gupta N, Nagpal M, Pawar P, Nanotechnology: A New Approach For Ocular Drug Delivery System, International Journal Of Pharmacy And Pharmaceutical Sciences, 4(2), 2012, 105-112.
52. Dhiman, S Dharmila and Thakur, GS “Nanosuspension: A recent approach for nano drug delivery system”, Int J Curr Pharm Res, Vol 3, Issue 4, 96-1015.
53. Aulton M.E. “Suspension” Pharmaceutics-the Science of Dosage Form Design, Churchill Livingstone, Edinburgh Second Edition, 2002; Page No. 84-86, 273.
54. Ansel C, Allen L.V, Popovich N.G. “Disperse Systems” Pharmaceutical Dosage Forms & Drug Delivery Systems, Lippincott Williams and Wilkins, Philadelphia, Eighth Edition, 2005; Page No. 387-389, 398.
55. Banker G.S. Rhodes C.T. “Dispersed Systems” Modern Pharmaceutics, Marcel Dekker, Inc. New York, 1979; 72: Page No. 345-346.
56. Cooper & Gun, “Dispersed System” Tutorial Pharmacy, Sixth Edition, Page No. 75- 78.
57. R. Santosh Kumar and T. Naga Satya Yagnesh, WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Volume 5, Issue 12, 1471-1537,.
